WELL Health (WELL) ran over 6% on the back of its $160M acquisition of two clinical platforms in Quebec and Ontario, adding over $20M of margin-accretive EBITDA per year…

… and bringing its Canadian clinic count to ~270. That prompted a guidance bump from management, who now expects to exit 2026 above the top end of its previous $175-185M EBITDA range…

… putting some distance between the company and consensus, which currently sits at $178M. The move higher implies estimates will move to $189M…

… which could leave more upside depending on what target the company puts out alongside Q2 results in August.

You might be interested in…

Disclaimer: Content on this site, including research reports, is provided by Bullpen Finance Inc. for informational purposes only and does not constitute investment advice. Bullpen Finance Inc. receives compensation from issuers for research coverage; such compensation does not influence opinions expressed. For complete disclosures, please see our Legal & Disclosures section.